|
1) Berger J, Hinglais N. Intracapillary deposits of IgA-IgG. J Urol Nephrol. 1968; 74: 694-5
|
|
|
|
|
2) Pierucci A, Fofi C, Bartoli B, et al. Antiendomysial antibodies in Berger's disease. Am J Kidney Dis. 2002; 39: 1176-82
|
|
|
|
|
3) Coppo R, Amore A, Gianoglio B, et al. Serum IgA and macromolecular IgA reacting with mesangial matrix components. Contrib Nephrol. 1993; 104: 162-71
|
|
|
|
|
|
4) Suzuki S, Nakatomi Y, Sato H, et al. Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA nephropathy. Lancet. 1994; 343: 12-6
|
|
|
|
|
|
5) Koyama A, Sharmin S, Sakurai H, et al. Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int. 2004; 66: 121-32
|
|
|
|
|
|
6) Gharavi AG, Yan Y, Scolari F, et al. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat Genet. 2000; 26: 354-7
|
|
|
|
|
|
7) Takei T, Iida A, Nitta K, et al. Association between single-nucleotide polymorphisms in selectin genes and immunoglobulin A nephropathy. Am J Hum Genet. 2002; 70: 781-6
|
|
|
|
|
|
8) Akiyama F, Tanaka T, Yamada R, et al. Single-nucleotide polymorphisms in the class II region of the major histocompatibility complex in Japanese patients with immunoglobulin A nephropathy. J Hum Genet. 2002; 47: 532-8
|
|
|
|
|
9) Obara W, Iida A, Suzuki Y, et al. Association of single-nucleotide polymorphisms in the polymeric immunoglobulin receptor gene with immunoglobulin A nephropathy (IgAN) in Japanese patients. J Hum Genet. 2003; 48: 293-9
|
|
|
|
|
|
10) Ohtsubo S, Iida A, Nitta K, et al. Association of a single-nucleotide polymorphism in the immunoglobulin mu-binding protein 2 gene with immunoglobulin A nephropathy. J Hum Genet. 2005; 50: 30-5
|
|
|
|
|
|
11) Suzuki H, Suzuki Y, Narita I, et al. Toll-like receptor 9 affects severity of IgA nephropathy. J Am Soc Nephrol. 2008; 19: 2384-95
|
|
|
|
|
|
12) Floege J, Burg M, Kleim V. Recurrent IgA nephropathy after kidney transplantation: not a benign condition. Nephrol Dial Transplant. 1998; 13: 1933-5
|
|
|
|
|
|
13) Cuevas X, Lloveras J, Mir M, et al. Disappearance of mesangial IgA deposits from the kidneys of two donors after transplantation. Transplant Proc. 1987; 19: 2208-9
|
|
|
|
|
|
14) Barratt J, Feehally J. IgA nephropathy. J Am Soc Nephrol. 2005; 16: 2088-97
|
|
|
|
|
|
15) Conley ME, Cooper MD, Michael AF. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest. 1980; 66: 1432-6
|
|
|
|
|
|
16) Tomino Y, Endoh M, Nomoto Y, et al. Immunoglobulin A1 and IgA nephropathy. N Engl J Med. 1981; 305: 1159-60
|
|
|
|
|
|
17) Novak J, Julian BA, Tomana M, et al. Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol. 2001; 21: 310-27
|
|
|
|
|
|
18) Coppo R, Amore A. Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int. 2004; 65: 1544-7
|
|
|
|
|
|
19) Moldoveanu Z, Wyatt RJ, Lee JY, et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int. 2007; 71: 1148-54
|
|
|
|
|
|
20) Allen AC, Bailey EM, Brenchley PE, et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients. Kidney Int. 2001; 60: 969-73
|
|
|
|
|
|
21) Hiki Y, Odani H, Takahashi M, et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 2001; 59: 1077-85
|
|
|
|
|
|
22) Suzuki H, Moldoveanu Z, Hall S, et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest. 2008; 118: 629
|
|
|
|
|
|
23) Yamada K, Kobayashi N, Ikeda T, et al. Down-regulation of core 1 (1, 3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1. Nephrol Dial Transplant. 2010; 25: 3890-7
|
|
|
|
|
|
24) Gharavi AG, Moldoveanu Z, Wyatt RJ, et al. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol. 2008; 19: 1008-14
|
|
|
|
|
|
25) van der Boog PJ, van Kooten C, de Fijter JW, et al. Role of macromolecular IgA in IgA nephropathy. Kidney Int. 2005; 67: 813-21
|
|
|
|
|
|
26) Hotta O, Miyazaki M, Furuta T, et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001; 38: 736-43
|
|
|
|
|
|
27) Xie Y, Chen X, Nishi S, et al. Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy. Kidney Int. 2004; 65: 1135-44
|
|
|
|
|
|
28) Komatsu H, Fujimoto S, Hara S, et al. Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. Clin J Am Soc Nephrol. 2008; 3: 1301-7
|
|
|
|
|
|
29) Suzuki Y, Tomino Y. Potential immunopathogenic role of the mucosa-bone marrow axis in IgA nephropathy: Insights from animal models. Seminars Nephrol. 2008; 28: 66-77
|
|
|
|
|
|
30) Suzuki Y, Tomino Y. The mucosa-bone-marrow axis in IgA nephropathy. Contrib Nephrol. 2007; 157: 70-9
|
|
|
|
|
|
31) Tomana M, Novak J, Julian BA, et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest. 1999; 104: 73-81
|
|
|
|
|
|
32) Suzuki H, Fan R, Zhang Z, et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest. 2009; 119: 1668-77
|
|
|
|
|
|
33) Gomez-Guerrero C, López-Armada MJ, González E, et al. Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-α and IL-6, and proliferation. J Immunol. 1994; 153: 5247-55
|
|
|
|
|
|
34) Novak J, Tomana M, Matousovic K, et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int. 2005; 67: 504-13
|
|
|
|
|
|
35) Lai KN, Leung JC, Chan LY, et al. Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. Nephrol Dial Transplant. 2009; 24: 62-72
|
|
|
|
|